Endocrine disruptors and female reproductive toxicity
FREIA
– named after the Nordic fertility goddess – was an EU-funded research project dedicated to advancing test methods to identify endocrine disrupting chemicals that are toxic to women’s health. The project, of which HEAL is a partner, was a collaboration between 11 institutes from seven European countries and the USA. The FREIA project officially ended on 30 June 2024.
Project objectives:
The main objective of this project was to provide dedicated, human-relevant, test methods to identify EDCs that cause female reproductive toxicity.
FREIA generated and integrated scientific data on the effects of EDCs on female reproductive health, specifically on ovarian development and function and the subsequent consequences for female fertility. These data was used to develop a test strategy with dedicated test methods to assess female reproductive toxicity and provide the basis to develop health preventive options.
